Indicated for: Oxidative stress, Alzheimers disease, Parkinsons disease, Cardiovascular disease (atherosclerosis), Type 2 diabetes, Rheumatoid arthritis, Chronic fatigue syndrome, Non-alcoholic fatty liver disease (NAFLD), Hepatitis C, Liver cirrhosis, Alcoholic fatty liver disease (alcoholic fatty liver disease), Liver failure, Diabetic neuropathy and retinopathy, Tremor, muscle stiffness and postural instability, Inflammatory bowel disease (Crohns disease, ulcerative colitis), Chronic asthma, Psoriasis, Heavy metal poisoning (mercury, lead), Chemotherapy, Recurrent infections, HIV/AIDS
Phase 2 data published in The New England Journal of Medicine in 2023 suggest meaningful weight reductions can begin within the first few months of treatment, with results continuing to build over 48 weeks
Watanabe F, Hashizume E, Chan GP, Kamimura A
Now if somebody has a cough of cold and infection, these numbers are going to be quite high I had a patient come in with an ulcerative colitis, and it was seventy one
